• Developed by Navarrabiomed's Childhood and Adolescent Physical Activity Research Unit

The Diactive-1 project, led by the Childhood and Adolescent Physical Activity Research Unit at Navarrabiomed in collaboration with the Navarra University Hospital (HUN/NOU), ANADI, and managed through IdiSNA, has been awarded the ITEMAS-ISCIII Quality Seal. This recognition endorses its scientific and technical quality, level of maturity, and transfer potential as an innovative digital health solution.

Diactive-1 stems from a well-established line of research developed through projects funded by the Carlos III Health Institute (PI21/01238), focused on improving the safety, personalization, and effectiveness of physical exercise among children and adolescents with type 1 diabetes.

The project has been materialized as a mobile application designed to facilitate safe physical activity tailored to each user's needs. The tool provides personalized strength training programs, therapeutic education content, and recommendations aimed at maintaining glucose stability during exercise. Its goal is to support the integration of physical activity into disease management and contribute to improving the health and quality of life of children and adolescents living with type 1 diabetes.

Recognition of its transfer potential

According to the evaluation report, Diactive-1 addresses a significant clinical need and demonstrates strong potential for implementation within Spain's National Health System. The report also highlights the advanced stage of development achieved by the project and its capacity to progress toward future validation and implementation phases.

One of its key strengths is its current presence in 11 hospitals (PI24/00829), which facilitates the generation of evidence in real-world clinical settings and supports its future incorporation into routine healthcare practice.

"Receiving the ITEMAS-ISCIII Quality Seal is a major endorsement for Diactive-1 because it recognizes not only the project's scientific and technological quality, but also its transfer potential and possible impact on clinical practice," said Antonio García-Hermoso, Principal Investigator of the project and Associate Professor at the Public University of Navarra (UPNA).

Promoting technology valorization

The achievement of this recognition has been made possible through the joint efforts of the research team and Navarrabiomed's Scientific-Technical Innovation Service, which has supported the project's maturation process and the development of its transfer strategy. As part of this process, Diactive-1 has registered its trademark (No. 019322598), strengthening its identity and positioning as an innovative digital solution for pediatric type 1 diabetes management in individuals aged 8 to 18 years.

"This recognition highlights the importance of addressing technology transfer from the very early stages of research projects. In the case of Diactive-1, an accompanying process has enabled us to consolidate its value proposition, define its protection strategy, and prepare a competitive application for the ITEMAS-ISCIII Quality Seal," explained Beatriz Pérez, Head of Navarrabiomed's Scientific-Technical Innovation Service.

Research aimed at making an impact

With this distinction, Diactive-1 further strengthens its position as a digital solution designed to address a real clinical need and with the potential for integration into the healthcare system. The project combines scientific evidence, clinical expertise, and technology to promote safer and more personalized physical exercise among children and adolescents with type 1 diabetes. "This is a step toward helping young people with type 1 diabetes feel a little freer," said Ignacio Hormazabal and Jacinto Muñoz, researchers involved in the project.

The award of the ITEMAS-ISCIII Quality Seal also incorporates Diactive-1 into a national network of innovative initiatives with potential application in the healthcare system. Navarrabiomed is part of ITEMAS as an associated entity, a platform of the Carlos III Health Institute (ISCIII) that promotes healthcare innovation and technology transfer through a network comprising more than one hundred hospitals, institutes, and research centers. This collaboration supports the development, validation, and adoption of innovations designed to address the real needs of patients and healthcare professionals, helping projects such as Diactive-1 advance toward practical implementation within the healthcare system.